EN | TR
E-ISSN: 3061-9947
Can Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and APRI Score Reliably Differentiate Uterine Sarcomas from Leiomyomas?
PDF
Cite
Share
Request
Original Article
VOLUME: 55 ISSUE: 2
P: 85-92
2022

Can Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and APRI Score Reliably Differentiate Uterine Sarcomas from Leiomyomas?

Acta Haematol Oncol Turc 2022;55(2):85-92
DOI: 10.5505/aot.2022.50570
Sezin Ertürk Aksakal 1
Hilal Korkmaz 2
Vakkas Korkmaz 3
1. Department of Gynecology, University of Health Sciences Etlik Zubeyde Hanim Women’s Health Training And Research Hospital, Ankara
2. Department of Physiology, Gazi University Faculty of Medicine, Ankara
3. Depertment of Gynecologic Oncology, University of Health Sciences Etlik Zubeyde Hanim Women’s Health Training And Research Hospital, Ankara
4.
No information available.
No information available
Received Date: 2021-11-07T22:51:48
Accepted Date: 2022-08-01T05:53:01
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Uterin sarcomas are one of the agresive gynecologic malignencies. There is still no optimal test for preoperative diagnosis of uterin sarcomas. The aim of this study was to evaluate the role of NLR, PLR, and APRI score in predicting preoperative uterine sarcoma.

METHODS

Patients operated on between January 2010 and December 2020 histopathologically diagnosed as sarcoma were included in the study group. Patients who were histopathologically diagnosed with M. uteri were included as the control group during the same period. Age, BMI (body mass index), gravida, parity, preoperative mean platelet volume (MPV), platelet distribution width (PDW), red cell distribution width (RDW), NLR,PLR and APRİ scores were recorded.

RESULTS

When comparing patients with fibroids and sarcomas, hemoglobin [12.3 g/dl (6.4-15.4) vs. 11.3 g/dl (6-17), p=0.008, respectively], hematocrit [38.5% (22-48.7) vs. 35.9% (21.4-52.1), p=0.002, respectively] and lymphocyte levels [2.2 103/ L (0.9-13.8) vs. 1.8 103/ L (1-2.6), p 0.001, respectively] were significantly lower and NLR [1.7 (0.2-10.1) vs. 2.3 (1.4-5.9), p 0.001, respectively] and PLR [124 (10.9-352.1) vs. 180.4 (84.9-284.3), p 0.001, respectively] were significantly higher in sarcoma group. The optimal cut-off value for NLR and PLR was calculated to be 2.04 with sensitivity and specificity of 59.4% and 59.5%, respectively, and 150.7 with sensitivity and specificity of 65.6% and 64.7%, respectively.

DISCUSSION AND CONCLUSION

Preoperative NLR and PLR rates can be useful markers for diagnosing uterine sarcoma. Randomized controlled large series studies are necessary to make a definitive statement.